ESTRO Multidisciplinary Management of Breast Cancer 2017

Previous Page

Next Page

Page Background

Neoadjuvant chemotherapy

Downstaging of disease and facilitation of less surgery

Better prognostication

New clinical trial opportunities

Tissue-based research for translational science